Trade setup intelligence
Charts, patterns, liquidity, and profile weighting stay together before a setup is surfaced.
Signal through the silt.
Stocks, crypto and news catalysts, ranked into decisions
Follow market prices, charts and current catalysts without an account. When you need a decision workflow, move into ranked intelligence with data-quality checks and risk-aware review.
- Public markets
- Stocks · Crypto · NFTs
- Catalysts
- Source attributed
- Member intelligence
- Risk gated
Automated Market Intelligence
News Catalysts Mixed Directly with Stock Signals
News aggregation engine
Market-moving headlines are normalized, scored, and matched to the stocks they can move.
Automated controls
Automation is gated by data quality, risk limits, and explicit confidence thresholds.
Signal Workflow
Built Around the Decision Path
Ingest
Market headlines and bars enter one data-quality boundary.
Score
Catalysts are separated into bullish, neutral, and bearish context.
Rank
Opportunity boards blend catalyst impact with chart and risk signals.
Control
Execution-facing actions stay behind operator and risk checks.
Current Catalysts
Latest Market Headlines
Source-attributed headlines captured in the last hours, each linked to the public stock and crypto pages it mentions. Browse all market news
Loihde Plc: Share Repurchase 19.10.2026 - 23.10.2026
Loihde Plc reported its share repurchase activities conducted between October 19 and October 23, 2026.
Inderes Adjusts Consti Price Target
Inderes has lowered its price target for Consti to 11.00 euro from the previous 11.50 euro while maintaining an 'increase' rating.
LeadDesk Plc Announces Composition of Shareholders' Nomination Committee
LeadDesk Plc has announced the composition of its Shareholders' Nomination Committee, a standard corporate governance procedure.
Inderes Raises Price Target for Modulight
Financial research firm Inderes has increased its price target for Modulight Oyj while maintaining a 'reduce' rating.
Nexera Technologies Ltd. Announces Agreement to Sell KeepZone AI Inc.
Nexera Technologies Ltd. has entered into a definitive agreement to sell its wholly owned subsidiary, KeepZone AI Inc., to a global aerospace and defense company for up to $6 million.
Nexentis Technologies' Subsidiary MitoCareX Bio Completes Initial Computational Screening with Boltz
Nexentis Technologies Inc. announced that its subsidiary, MitoCareX Bio Ltd., has finished the first computational screening phase of its drug-discovery collaboration with AI research lab Boltz, PBC.
Real signals or no signal
The system only ranks opportunities when real market and catalyst data is available. Missing data produces a clear unavailable state instead of noise.
Review integrations